Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PET imaging agent manufacturers can file for certain GMP exemptions, agency guidance states.

Executive Summary

PET AGENTS MANUFACTURERS CAN FILE FOR GMP REGS EXEMPTIONS in certain conditions under an FDA proposed rule pertaining to radiopharmaceuticals used in positron emission tomography published in the Feb. 27 Federal Register. The rule is "intended to relieve PET manufacturers, nearly all of whom are small entities, from regulations that might result in unsafe handling of PET radiopharmaceuticals...or otherwise do not enhance the safety or quality" of the drug products. Because of their short half-lives, some only minutes long, the radiotracers are generally made to fill daily demands and are not commercially distributed. The agents are often made at the same facility in which they are used.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025852

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel